CD4+ T Cells Cooperate With Macrophages for Specific Elimination of MHC Class II-Negative Cancer Cells

This publication has 42 references indexed in Scilit:

• Innate NKT lymphocytes confer superior adaptive immunity via tumor-capturing dendritic cells
  The Journal of Experimental Medicine, 2005
• Primary Antitumor Immune Response Mediated by CD4+ T Cells
  Immunity, 2005
• Anti‐Class II Antibodies, but not Cytotoxic T‐Lymphocyte Antigen 4–Immunoglobulin Hybrid Molecules, Prevent Rejection of Major Histocompatibility Complex Class II‐Negative Myeloma in T‐Cell Receptor‐Transgenic Mice
  Scandinavian Journal of Immunology, 2004
• Tumour-educated macrophages promote tumour progression and metastasis
  Nature Reviews Cancer, 2004
• Therapeutic effect of idiotype-specific CD4+ T cells against B-cell lymphoma in the absence of anti-idiotypic antibodies
  Blood, 2003
• The role of tumour‐associated macrophages in tumour progression: implications for new anticancer therapies
  The Journal of Pathology, 2002
• Critical Role for Tumor Necrosis Factor–related Apoptosis-inducing Ligand in Immune Surveillance Against Tumor Development
  The Journal of Experimental Medicine, 2002
• Tumor Cell Responses to IFNγ Affect Tumorigenicity and Response to IL-12 Therapy and Antiangiogenesis
  Immunity, 1998
• Specific T Helper Cell Requirement for Optimal Induction of Cytotoxic T Lymphocytes against Major Histocompatibility Complex Class II Negative Tumors
  The Journal of Experimental Medicine, 1998
• In vivo priming of two distinct antitumor effector populations: the role of MHC class I expression.
  The Journal of Experimental Medicine, 1994